3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
4
Neoplasm Metastasis
3
Multiple Myeloma
3
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Hematologic Neoplasms
1
HER2 Positive Breast Cancer
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
23
fludarabine
14
Rituximab
14
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Doxorubicin
7
pirtobrutinib
6
Vincristine
6
Prednisone
6
zanubrutinib
4
polatuzumab vedotin
4
obinutuzumab
4
Nivolumab
4
Etoposide
4
Dexamethasone
4
Biopsy
4
tazemetostat
3
tafasitamab
3
pembrolizumab
3
ibrutinib
3
glofitamab
3
fludarabine phosphate
3
acalabrutinib
3
Immunotherapy, Adoptive
3
Bendamustine Hydrochloride
3
venetoclax
2
pomalidomide
2
etoposide phosphate
2
cemiplimab
2
Prednisolone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
copanlisib
×
90 days
×
Clear all
No trials found.